|
OMIM |
Link |
Information gain |
01 |
|
ALB
|
[NCBI]
|
0.00100964
|
|
|
glomerulopathy with fibronectin deposits
|
[NCBI]
|
0.000787083
|
|
|
renal failure, progressive, with hypertension
|
[NCBI]
|
0.000697531
|
|
|
abdominal obesity-metabolic syndrome
|
[NCBI]
|
0.0006318
|
|
|
alport syndrome, autosomal dominant
|
[NCBI]
|
0.000489961
|
|
|
SLE
|
[NCBI]
|
0.000381685
|
|
|
CTGF
|
[NCBI]
|
0.000194275
|
|
|
VEGF
|
[NCBI]
|
0.000105533
|
|
|
deafness, cochlear, with myopia and intellectual impairment
|
[NCBI]
|
0.000105351
|
|
|
diabetic nephropathy, susceptibility to
|
[NCBI]
|
9.68753e-05
|
|
|
ACE
|
[NCBI]
|
9.12334e-05
|
|
|
donnai-barrow syndrome
|
[NCBI]
|
8.13165e-05
|
|
|
EPO
|
[NCBI]
|
7.60098e-05
|
|
|
FBS
|
[NCBI]
|
6.35713e-05
|
|
|
ALMS
|
[NCBI]
|
5.86403e-05
|
|
|
SLC2A2
|
[NCBI]
|
5.76e-05
|
|
|
CGL2
|
[NCBI]
|
5.74727e-05
|
|
|
SDC2
|
[NCBI]
|
5.73839e-05
|
|
|
OCRL
|
[NCBI]
|
5.48822e-05
|
|
|
CYP24A1
|
[NCBI]
|
4.24169e-05
|
|
|
NPPA
|
[NCBI]
|
4.03375e-05
|
|
|
PG
|
[NCBI]
|
3.91763e-05
|
|
|
LAMB2
|
[NCBI]
|
3.87737e-05
|
|
|
PON2
|
[NCBI]
|
3.87737e-05
|
|
|
GYS1
|
[NCBI]
|
3.87737e-05
|
|
|
MAP2K1
|
[NCBI]
|
3.73601e-05
|
|
|
danubian endemic familial nephropathy
|
[NCBI]
|
3.6867e-05
|
|
|
IL6
|
[NCBI]
|
3.40108e-05
|
|
|
CAV1
|
[NCBI]
|
3.15807e-05
|
|
|
AKR1B1
|
[NCBI]
|
2.95803e-05
|
|
|
RBP4
|
[NCBI]
|
2.7507e-05
|
|
|
ENPEP
|
[NCBI]
|
2.50233e-05
|
|
|
CP
|
[NCBI]
|
2.33925e-05
|
|
|
ADIPOQ
|
[NCBI]
|
2.24921e-05
|
|
|
MBL2
|
[NCBI]
|
2.22748e-05
|
|
|
UGB
|
[NCBI]
|
2.02907e-05
|
|
|
PTH
|
[NCBI]
|
1.99105e-05
|
|
|
HGF
|
[NCBI]
|
1.98985e-05
|
|
|
AQP2
|
[NCBI]
|
1.92664e-05
|
|
|
TGFB1
|
[NCBI]
|
1.83482e-05
|
|
|
CAT
|
[NCBI]
|
1.74854e-05
|
|
|
GAPDH
|
[NCBI]
|
1.69958e-05
|
|
|
LPL
|
[NCBI]
|
1.63992e-05
|
|
|
CPB2
|
[NCBI]
|
1.63347e-05
|
|
|
LEPR
|
[NCBI]
|
1.542e-05
|
|
|
TF
|
[NCBI]
|
1.47865e-05
|
|
|
PLAUR
|
[NCBI]
|
1.32565e-05
|
|
|
ILK
|
[NCBI]
|
1.2532e-05
|
|
|
FMF
|
[NCBI]
|
1.09461e-05
|
|
|
LEP
|
[NCBI]
|
1.04309e-05
|
|
|
CF
|
[NCBI]
|
9.30535e-06
|
|
|
PPARA
|
[NCBI]
|
9.05655e-06
|
|
|
ADM
|
[NCBI]
|
8.7544e-06
|
|
|
TTR
|
[NCBI]
|
8.53903e-06
|
|
|
PI
|
[NCBI]
|
4.85281e-06
|
|
|
APOE
|
[NCBI]
|
4.46934e-06
|
|
|
HP
|
[NCBI]
|
3.75129e-06
|
|
|
RA
|
[NCBI]
|
3.57051e-06
|
|
|
AR
|
[NCBI]
|
3.48266e-06
|
|
|
PF4
|
[NCBI]
|
3.0499e-06
|
|
|
TLR4
|
[NCBI]
|
2.9833e-06
|
|
|
TNF
|
[NCBI]
|
2.65489e-06
|
|
|
TFPI
|
[NCBI]
|
2.31487e-06
|
|
|
XDH
|
[NCBI]
|
2.21008e-06
|
|
|
EGF
|
[NCBI]
|
9.89585e-07
|
|
|
TNFRSF11B
|
[NCBI]
|
5.07886e-07
|
|
|
SHBG
|
[NCBI]
|
4.85061e-07
|
|
|
F3
|
[NCBI]
|
1.40962e-07
|
|
|
NPY
|
[NCBI]
|
1.0149e-07
|
|
|
PCNA
|
[NCBI]
|
4.61029e-09
|
|
|
AVP
|
[NCBI]
|
1.51309e-09
|
|
|
RNASE3
|
[NCBI]
|
4.17893e-10
|
|